Follows people with Parkinson's disease to track how it changes over time
Studies clinical features and biomarkers of Parkinson's disease in adults aged 30 to 75.
Plain-language title generated from the registry record
Registry title: Chinese DENOVO PD Registry
Key facts
- Where
- Changsha, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
Source: NCT05767151, who can take part
Where in China
- Xiangya Hospital of Central South UniversityChangsha, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xiangya Hospital of Central South University
- Trial code
- NCT05767151
- Record updated
- 14 March 2023
- Original description
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.Read full original descriptionShow less
The Chinese DENOVO Parkinson's Disease Registry
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.
Inclusion: Participants were diagnosed by MDS Clinical Diagnostic Criteria for PD; Disease duration ≤ 2 years at baseline; Hoehn-Yahr stage ≤2 at baseline; The age of PD patients ranges from 30 to 75 years old; Participants were naive to antiparkinsonian therapy; Able to Written informed consent.
Exclusion: Participants were treated with antiparkinsonian drugs at baseline; Participants were diagnosed with parkinsonism-syndrome; Participants with cognitive impairment; Unable to Written informed consent.